about
Allergy immunotherapy across the life cycle to promote active and healthy ageing: from research to policies: An AIRWAYS Integrated Care Pathways (ICPs) programme item (Action Plan B3 of the European Innovation Partnership on active and healthy ageinCiprofloxacin-induced glottic angioedemaParietaria pollinosis in an Atlantic area: clinical and palynological data.Relationship of clinical and aerobiological pollen data in the north-west of Spain.An EAACI "European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI)": the methodologyTotal serum IgE levels in chronic hepatitis C: influence of interferon alpha therapy.Evaluation of the phadiatop test in the diagnosis of allergic sensitization in a general adult population.Diagnosis and allergen immunotherapy treatment of polysensitised patients with respiratory allergy in Spain: an Allergists' Consensus.Alcohol, IgE and allergy.Serum Concentrations of IgG4 in the Spanish Adult Population: Relationship with Age, Gender, and Atopy."A year-long, fortnightly, observational survey in three European countries of patients with respiratory allergies induced by house dust mites: Methodology, demographics and clinical characteristics".The association of the 'additional height index' with atopic diseases, non-atopic asthma, ischaemic heart disease and mortality: a population-based studySafety evaluation of rapid build-up schedules with IR-standardized allergen extracts for subcutaneous immunotherapy of allergic respiratory diseases.European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): a real-life clinical assessment.The European Survey on Adverse Systemic Reactions in Allergen Immunotherapy (EASSI): A paediatric assessment.Engineering of major house dust mite allergens Der p 1 and Der p 2 for allergen-specific immunotherapy.Factors Influencing Serum Concentrations of Immunoglobulin D in the Adult Population: An Observational Study in Spain.Minor interference of cross-reactive carbohydrates with the diagnosis of respiratory allergy in standard clinical conditions.Immunoglobulin E sensitization to cross-reactive carbohydrate determinants: epidemiological study of clinical relevance and role of alcohol consumption.Anaphylactoid reaction to hydroxycobalamin with tolerance of cyanocobalamin.Incidence and remission of specific IgE aeroallergen sensitization from age of 40 to 60 years, and association with alcohol consumption.Diagnosis and treatment of allergic rhinitis due to house-dust mites in Spain.Comparison of montelukast versus budesonide in the treatment of exercise-induced bronchoconstriction.Validation of the first treatment-specific questionnaire for the assessment of patient satisfaction with allergen-specific immunotherapy in allergic patients: the ESPIA questionnaire.Association of alcohol consumption with total serum immunoglobulin E levels and allergic sensitization in an adult population-based survey.Pancreatitis, alcohol and immunoglobulin E.Component-resolved diagnosis of pollen allergy based on skin testing with profilin, polcalcin and lipid transfer protein pan-allergens.Association of hepatitis A virus infection with allergic sensitization in a population with high prevalence of hepatitis A virus exposure.Immunoglobulin-E reactivity to a glycosylated food allergen (peanuts) due to interference with cross-reactive carbohydrate determinants in heavy drinkers.Acoustic rhinometry after nasal provocation test, 6 months interim analysis of alumites study, a randomized, controlled, multicentre phase IV study with house dust mites subcutaneous immunotherapy.Discordant positive results of multiallergen immunoglobulin E tests in relation to crossreactive carbohydrate determinants and alcohol consumption.Sensitization to cross-reactive carbohydrate determinants in relation to alcohol consumption.Challenges in the implementation of the EAACI AIT guidelines: A situational analysis of current provision of allergen immunotherapy.IgE antibodies to alpha-gal in the general adult population: relationship with tick bites, atopy, and cat ownership.Prevalence of self-reported hypersensitivity symptoms following intake of alcoholic drinks.Total and Honeybee Venom-Specific Serum IgG4 and IgE in Beekeepers.House dust mite species and allergen levels in Galicia, Spain: a cross-sectional, multicenter, comparative study.Randomized dose-response study of subcutaneous immunotherapy with a Dermatophagoides pteronyssinus extract in patients with respiratory allergy.Association Between Asthma and Sensitization to Allergens of Dermatophagoides pteronyssinus.Anaphylaxis to Hippobosca equina (louse fly).
P50
Q28077951-EB4BB856-E386-4372-8B14-11C0870041A5Q28367837-8137C4D9-7B28-472E-8ED2-13BCCC0B43CFQ30663044-9A495B6F-BFB7-41CF-A631-492F9E671F27Q30688451-DA15DDB9-7313-41BC-BA43-28685FA2684FQ33962778-4FA9C95E-CE90-4C84-B761-C49070CE5897Q34298108-38636A42-674E-4228-B989-B3360047E639Q34437506-4DF5933D-F023-426A-9BA5-69FB3A275C42Q35101859-324778F9-6F0F-4AEC-98FD-B77D0B429F0EQ35931633-9F77F523-ED23-4D7F-9912-1A3A11357592Q35934155-F0922533-CF7F-4AF0-9663-CE2C4F9DCD1BQ36026957-55BC751B-D53B-497D-8272-31791FD432D1Q37612155-9E7FED7A-E71F-4A5D-92EA-07BCE2BBD39BQ37902666-790AD749-B6C8-4070-8EF1-35B6FAEBF2EDQ39310240-260FFA68-0901-49B6-B45C-BBD63EA974F6Q39380921-F931F8E5-EAA6-45D6-A91B-0B3C38181605Q39984129-0EC0DCBE-4D14-48F7-B34F-6277AEE96A39Q40362199-C381C4C1-2FAA-42D4-A1C0-1ADA8D25F88FQ42726151-014CB0EE-FE1E-4A0F-9C25-2173788528ADQ43112814-B130ED74-AA80-4685-8CF0-21750E778648Q43228422-0C0ECAC4-5E7D-4DBC-ACA8-3B23909D6BBFQ43276841-162843A2-C06E-4CA8-9580-6C5EC08B0EADQ43499643-420BA48D-0A29-446D-8C18-3B099AAB1A89Q43655204-467E4847-BCB7-4232-BA4D-A21925455630Q43919766-779DD0BA-B176-4A33-9B9F-024069595479Q44311493-70ACBB82-8692-45C3-8DDA-1A3A4914EF72Q44981249-08A0EDEA-8AC9-482A-9EDE-DFB308250D38Q45160877-2D78BBF0-56C6-4867-B272-BE9D84E76C3EQ45541298-75F0D4D2-9291-4BC4-8161-E094E61D22E1Q46026538-FD9253E5-1499-434B-9714-DE7F56D36468Q46028923-B6C592E3-13F3-4D57-A377-234D004BAE7AQ46093677-1573ACFE-A5D3-43FE-8318-2055981A9143Q46916800-959AFCD0-4195-42AA-9A27-CEC99BF27911Q47570104-EADC3078-91EE-48C5-9579-D2BD630ABEECQ50473371-DDC889F6-A999-4EB4-8E87-6C8782D2983CQ50674011-49250C12-5A90-4D87-B361-5AD1E55C44F1Q51063778-34A50D4C-4333-4A03-B68D-AA2AA68E302DQ51177679-1BB744C2-C762-4AAD-B3BA-AE2832E56048Q51557000-016B74CD-C6AA-4ABF-B968-77422F6B3656Q51666325-6B9B7948-ECC6-4746-997E-DA415689E2CBQ52684441-47F2B9AA-9BE6-4FD9-9237-9CA59C9E8A29
P50
description
Forscher
@de
chercheur
@fr
investigador
@es
researcher
@en
ricercatore
@it
研究者
@zh
name
C Vidal
@ast
C Vidal
@en
C Vidal
@es
C Vidal
@nl
type
label
C Vidal
@ast
C Vidal
@en
C Vidal
@es
C Vidal
@nl
prefLabel
C Vidal
@ast
C Vidal
@en
C Vidal
@es
C Vidal
@nl
P31
P496
0000-0002-2844-2754